e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Pre-operative evaluation and post-operative problems after lung transplantation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The clinical relevance of mannose-binding lectin (MBL) in long term survival of lung transplant recipients
J. Kwakkel-van Erp, H. Otten, A. Paantjens, D. van Kessel, J. van den Bosch, J. Grutters, E. van de Graaf (Utrecht, Nieuwegein, Netherlands)
Source:
Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation
Session:
Pre-operative evaluation and post-operative problems after lung transplantation
Session type:
E-Communication Session
Number:
3480
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Kwakkel-van Erp, H. Otten, A. Paantjens, D. van Kessel, J. van den Bosch, J. Grutters, E. van de Graaf (Utrecht, Nieuwegein, Netherlands). The clinical relevance of mannose-binding lectin (MBL) in long term survival of lung transplant recipients. Eur Respir J 2010; 36: Suppl. 54, 3480
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Immunophenotype and gene signature of long-term survivors with normal allograft function after lung transplantation
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019
The impact of pre-transplant donor specific anti-HLA antibodies (DSAs) on lung transplant outcome: A single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019
Longitudinal assessment of CD4+CD25
high
CD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome
Source: Eur Respir J, 58 (5) 2004090; 10.1183/13993003.04090-2020
Year: 2021
Mannose binding lectin (MBL) levels predict lung function decline in severe asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 599s
Year: 2006
Mannose binding lectin (MBL) levels predict lung function decline in severe asthma
Source: Eur Respir Rev 2006; 15: 224-225
Year: 2006
Prevalence of pre-transplant anti-HLA antibodies and their impact on outcomes in lung transplant recipients
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010
Pretransplant factors influencing survival in cystic fibrosis (CF) patients after lung transplantation (LTx)
Source: Eur Respir J 2006; 28: Suppl. 50, 724s
Year: 2006
T-cell response against tuberculosis antigens is dependent on the level of immunosuppression in renal and lung transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 344s
Year: 2006
Do NHBD and HBD recipients have different airway inflammatory profiles early after LTx?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
The use of mTOR inhibitors is associated with improved survival in lung transplant recipients
Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Year: 2020
3
He-MRI in lung transplant recipients (LTR) in correlation with lung function tests
Source: Eur Respir J 2001; 18: Suppl. 33, 179s
Year: 2001
Analysis of the nasal microbiome in long-term survivors after lung transplantation with a good allograft function
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Pulmoanry hypertension is a negative prognostic factot of long term survival in patients with idiopathic pulmonary fibrosis after lung transplantation
Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Year: 2020
Impact of donor, recipient and matching on survival after high emergency lung transplantation in France
Source: Eur Respir J, 54 (5) 1900096; 10.1183/13993003.00096-2019
Year: 2019
6MWT as useful predictor for long term survival after lung transplantation in patients with ILD
Source: Virtual Congress 2020 – Clinical management of lung transplant recipients
Year: 2020
Late-breaking abstract: Non specific IgG replacement in lung transplantation recipients with low IgG plasma levels: Effects on survival and bronchiolitis obliterans syndrome occurrence
Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations
Year: 2011
Specificities of the paediatric lung transplant recipient
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept